<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02848703</url>
  </required_header>
  <id_info>
    <org_study_id>2015-45</org_study_id>
    <secondary_id>2016-A00026-45</secondary_id>
    <nct_id>NCT02848703</nct_id>
  </id_info>
  <brief_title>Study &quot; COFLORES &quot;</brief_title>
  <official_title>Study &quot; COFLORES &quot;:Imaging of Coronary Reserve Without Tracers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myocardial perfusion is a major parameter characterizing the status of capillary circulation
      of the myocardium. Its quantification is possible using Magnetic Resonance Imaging (MRI)
      during the 1st pass of a contrast agent through the capillary system. This technique is
      radiation-free, but it is difficult to repeat measurements during a single exam. Also, a
      number of patients suffering from cardiac disease cannot receive contrast agent injections.
      The investigators have developed a totally non-invasive approach for quantifying myocardial
      perfusion. It is based on the magnetic labeling of arterial spins. Flowing into the
      capillaries (Arterial spin labeling, ASL).

      Goal : The major goal of this research protocol is to validate a totally non-invasive method
      of myocardial blood flow quantification using MRI without contrast agent injection
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial perfusion</measure>
    <time_frame>1day</time_frame>
    <description>MRI based on the magnetic labeling of arterial spins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the myocardial energetic status</measure>
    <time_frame>1day</time_frame>
    <description>using phosphorus-31 Magnetic Resonance Spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the myocardial sodium</measure>
    <time_frame>1day</time_frame>
    <description>using sodium-23 MRI</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Myocardial Perfusion</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>phosphorus-31 Magnetic Resonance Spectroscopy</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sodium-23 MRI</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People having no heart disease or treatment referred to cardiology

          -  People having no cons -indications to MRI

          -  People having no cons -indications to gadolinium ;

          -  People not wearing implantable devices

          -  People not wearing metallic foreign bodies or risk (eg . Business of steel, etc .. )

          -  People having no cardiovascular risk factor

          -  Person subject to the social security scheme

          -  Nobody agreeing to participate in the study and who signed the informed consent

        Exclusion Criteria:

          -  Refusal to go spontaneous or MRI because of claustrophobia important

          -  Trouble rhythm making MRI uninterpretable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine GEINDRE</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ALEXIS JACQUIER</last_name>
    <email>alexis.jacquier@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra GIULIANI</last_name>
    <email>alexandra.giuliani@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ALEXIS JACQUIER, MD</last_name>
      <email>ajacquier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>alexis jacquier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2016</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

